Bionano Genomics, Inc. (BNGO)

1.17 -3.31% (-0.04)

Over 1Y: -69.6%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 4.7M Q3 '21 — Operating Cash Flow: -20M Q3 '21 — Free Cash Flow: -20.2M Q3 '21 — Net Income: -20.8M Q4 '21 — Revenue: 6.3M Q4 '21 — Operating Cash Flow: -25.6M Q4 '21 — Net Income: -22.9M Q1 '22 — Revenue: 5.7M Q1 '22 — Operating Cash Flow: -32.5M Q1 '22 — Net Income: -30M Q2 '22 — Revenue: 6.7M Q2 '22 — Operating Cash Flow: -28.3M Q2 '22 — Net Income: -32.2M Q3 '22 — Revenue: 7.2M Q3 '22 — Operating Cash Flow: -29.5M Q3 '22 — Net Income: -31.8M Q4 '22 — Revenue: 8.2M Q4 '22 — Operating Cash Flow: -34.5M Q4 '22 — Net Income: -38.7M Q1 '23 — Revenue: 7.4M Q1 '23 — Operating Cash Flow: -32.4M Q1 '23 — Free Cash Flow: -32.8M Q1 '23 — Net Income: -37.1M Q2 '23 — Revenue: 8.7M Q2 '23 — Operating Cash Flow: -36.7M Q2 '23 — Free Cash Flow: -37.2M Q2 '23 — Net Income: -38.9M Q3 '23 — Revenue: 9.3M Q3 '23 — Operating Cash Flow: -26.3M Q3 '23 — Free Cash Flow: -26.4M Q3 '23 — Net Income: -112.6M Q4 '23 — Revenue: 10.7M Q4 '23 — Operating Cash Flow: -29.8M Q4 '23 — Free Cash Flow: -30.5M Q4 '23 — Net Income: -43.9M Q1 '24 — Revenue: 8.8M Q1 '24 — Operating Cash Flow: -28.1M Q1 '24 — Free Cash Flow: -28.2M Q1 '24 — Net Income: -31.4M Q2 '24 — Revenue: 7.8M Q2 '24 — Operating Cash Flow: -21M Q2 '24 — Free Cash Flow: -21.1M Q2 '24 — Net Income: -16.2M Q3 '24 — Revenue: 6.1M Q3 '24 — Operating Cash Flow: -13.3M Q3 '24 — Free Cash Flow: -13.3M Q3 '24 — Net Income: -44.2M Q4 '24 — Revenue: 8.2M Q4 '24 — Operating Cash Flow: -6.5M Q4 '24 — Free Cash Flow: -6.5M Q4 '24 — Net Income: -20.1M Q1 '25 — Revenue: 6.5M Q1 '25 — Operating Cash Flow: -2.8M Q1 '25 — Free Cash Flow: -2.8M Q1 '25 — Net Income: -3.1M Q2 '25 — Revenue: 6.7M Q2 '25 — Operating Cash Flow: -3.5M Q2 '25 — Free Cash Flow: -3.5M Q2 '25 — Net Income: -6.9M Q3 '25 — Revenue: 7.4M Q3 '25 — Operating Cash Flow: -5.9M Q3 '25 — Free Cash Flow: -5.9M Q3 '25 — Net Income: -8.5M Q4 '25 — Revenue: 8M Q4 '25 — Operating Cash Flow: -4.2M Q4 '25 — Free Cash Flow: -4.2M Q4 '25 — Net Income: -7.9M Q1 '26 — Revenue: 6.7M Q1 '26 — Operating Cash Flow: -5.7M Q1 '26 — Net Income: -8.3M Q2 '26 — Revenue: 8.2M Q2 '26 — Operating Cash Flow: -4.7M Q2 '26 — Net Income: -7.4M -100M -75M -50M -25M 0 25M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.6
SBC / sales 11.6%
OE margin -79.5%
Oper. margin -106.7%
ROIC -100.2%
Accruals -24.5%
Gross margin 47.5%
EBITDA margin -75.8%
FCF margin -67.9%
OCF margin -67.9%
Profit margin -106.6%
ROA -67.6%
ROCE -85.7%
ROE -101.8%
Capex / sales —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.5
RPO / sales 0.043×
RPO growth -7.1%
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.2
ND/EBITDA —
Interest cover -23.8×
Cash / Debt 2.7×
Debt / Eq 0.12×
Debt payback 0.0 yr
Quick ratio 1.8×
Cash runway 0.3 yr
F-score 4.5 pts
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.2
Sales CAGR 4Y +12.2%
Sales/sh Y/Y -74.3%
Sales Q/Q +21.4%
Shares change +328.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.